Replies to post #512058 on NorthWest Biotherapeutics Inc (NWBO)

[iwasadiver]

They added “confirmed progression” to the list of secondary endpoints. This, and other endpoints, probably won’t be addressed in the publication but will be the subject of white papers and other evidence at conferences, etc. going forward.